Chronic Intestinal Pseudo-obstruction and Orthostatic Hypotension Associated with Small Cell Lung Cancer that Improved with Tumor Reduction after Chemoradiotherapy
暂无分享,去创建一个
Hiroshi Iwamoto | H. Iwamoto | N. Hattori | T. Nakashima | Taku Nakashima | Noboru Hattori | T. Masuda | K. Fujitaka | Y. Horimasu | Yusuke Izumi | Takeshi Masuda | Yasushi Horimasu | Shintaro Miyamoto | Kazunori Fujitaka | Hironobu Hamada | S. Miyamoto | H. Hamada | Yusuke Izumi
[1] J. Taverna,et al. The great masquerader of malignancy: chronic intestinal pseudo-obstruction , 2014, Biomarker Research.
[2] J. Honnorat,et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[3] Y. Hasegawa,et al. Integrated treatment for autonomic paraneoplastic syndrome improves performance status in a patient with small lung cell carcinoma: a case report , 2018, BMC Neurology.
[4] M. Camilleri,et al. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics , 2001, American Journal of Gastroenterology.
[5] L. Tang,et al. A Report of Chronic Intestinal Pseudo-obstruction Related to Systemic Lupus Erythematosus , 2018, Open medicine.
[6] N. Malats,et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Honnorat,et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force , 2006, European journal of neurology.
[8] D. Moskovitz,et al. Small cell lung cancer with positive anti-Hu antibodies presenting as gastroparesis. , 2002, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[9] C. Lucchinetti,et al. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies , 1998, Neurology.
[10] A. Nakajima,et al. A review of the reported cases of chronic intestinal pseudo-obstruction in Japan and an investigation of proposed new diagnostic criteria , 2011, Clinical journal of gastroenterology.
[11] S. Steinshamn,et al. Octreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLC. , 2005, Lung cancer.
[12] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.